ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629867 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629867; 2) Community: the network communities that were significantly associated with the response to NSC 629867; 3) Molecule: the relationships between components within communities and NSC 629867; 4) MDR: the compounds that were significantly associated with the NSC 629867.

NSC Compound Enrichment Correlation
NSC 672116 9-.alpha.-Acetoxyparthenolide 0.0228801759885687 0.075357461
NSC 677696 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester 0.0228801759885687 0.056169754
NSC 733504 Everolimus 0.0228801759885687 0.16602244
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0228801759885687 -0.08622267
NSC 692579 Null 0.0228801759885691 0.11948904
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0228801759885691 0.18422222
NSC 18805 .gamma.-Thujaplicine 0.0238174255956147 0.26071655
NSC 615291 Bizelesin 0.0238174255956147 0.25801642
NSC 615534 Null 0.0238174255956147 0.12308566
NSC 640735 3-(4-Methoxy-2-methylphenyl)naphthol [2,1-c]furan-1(3H)-one 0.0238174255956147 -0.012609329
Total:43  Current:15    [First] [Prev] [Next] [Last]